Hyaluronan-binding function of the CD44 molecule has not been so far detected in myeloid cells. To study pure populations of primitive myeloid cells, we investigated the hyaluronan-binding function of the CD44 molecule from three myeloid cell lines: KGla, KGI, and HL60. Both KGla and KG1 cells express the CD34 antigen characteristic of the hematopoietic stem cells and HL60 cells do not; accordingly, KGla and KG1 cells are generally considered as the most primitive and HL60 cells as the most mature of these cell lines. Measurement of cell adhesion to hyaluronancoated surfaces (using 6'Cr-labeled cells) and of aggregate formation in hyaluronan-containing solutions, showed that 45% of KG1 cells and 22% to 24% of KG1 a spontaneously bind to hyaluronan, whereas HL60 cells do not either spontaneously or after treatment with a phorbol ester. Hyaluronan binding by KGla and KG1 cells is mediated by CD44, because it is specifically abolished by monoclonal antibod-
M
YELOID CELLS develop within extravascular spaces of the bone marrow (BM) where they are in close contact with two main types of extracellular molecules produced by stromal cells: low molecular weight glycoproteins comprising cytokines and macromolecules such as collagens, fibronectin, and glycosaminoglycans.' Interest in studying the receptors for extracellular macromolecules has only arisen recently2-$ when it became evident that these extracellular macromolecules had not only a structural function but also were essential for the organized development of primitive myeloid cells into mature progeny. 6 CD44 is a transmembrane molecule with multiple isoforms generated by RNA alternative s p l i~i n g .~~~ It mediates the binding of lymphocytes, fibroblasts, and macrophages to hyaluronan, a major glycosaminoglycan component of extracellular matrix.'"' Hyaluronan binding by CD44 plays a role in adhesion of lymphoid cells to the BM stroma and possibly to lymphoid this binding has been seen to be either constitutive or inducible by phorbol esters or anti-CD44 monoclonal antibodies. [14] [15] [16] It seems worthwhile to study the functions of CD44 expressed on primitive myeloid cells, because the high expression of CD44 on marrow progenitor cell^,'^.'^ and the complete inhibition of lymphomyelopoiesis in liquid BM culture by antibodies to CD44I3 strongly suggested that CD44 played an important role in myelopoiesis. Until now, it has been reported thai, unlike lymphoid cells, CD44' myeloid cells were unable to bind hyaluronan even after treatment with phorbol However, these studies were only performed on a few myeloid cell lines and on the whole of BM cells, in which the proportion of primitive cells is very small.
Considering that hyaluronan is abundantly produced by BM stromal cells,l' we find it relevant to investigate the ability of homogeneous populations of primitive myeloid cells to bind hyaluronan by the means of CD44. For this purpose, we have studied three human cell lines: KGla, KGI, and HL60. These cell lines are interesting models of myeloid Primitive cells, because their differentiation is blocked at early steps of myelopoiesis. Expression of the CD34 antigen ies (MoAbs) to this molecule. The binding might require phosphorylation by protein kinase C and perhaps also by protein kinase A, because it is prevented by staurosporine. which inhibits these enzymes. 12-0-tetradecanoylphorbol-13-acetate (TPA) which activates protein kinase C, rises to 80% the proportion of KG1 and KG1 a cells that bind hyaluronan; this activation is dependent on protein synthesis, for it is abrogated by cyclophosphamide, a protein synthesis inhibitor. Binding of TPA-treated cells t o hyaluronan is only partly inhibited by MoAb to CD44: this suggests that TPA may induce synthesis of a hyaluronan-binding protein distinct from CD44. Considering the abundance of hyaluronan in human bone marrow, these results suggest that CD44 may be involved in mediating precursor-stroma interaction.
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on KG 1 and KG 1 a cells implies that these cells are highly primitive, and other antigenic features suggest that KGla cells are more primitive than KG 1
Because of their ability to differentiate in both granulocytic and macrophagic cells, HL60 cells are generally considered to be nearly as mature as granulomacrophagic p r~g e n i t o r s .~~ We presently show that KG1 and KGla cells spontaneously bind hyaluronan by the means of CD44, whereas HL60 cells do not even after treatment with phorbol ester. These results suggest that CD44 may be involved in the interaction ofprecursor cells with the hematopoietic stroma.
MATERIALS AND METHODS
Cell lines. KG 1 and KG 1 a were kindly provided by Dr Mannoni (Marseille, France). HL60 cells were purchased from the Human Mutant Cell Repository Institute for Medical Research (Camden, NJ). All these cells were maintained at 37"C, in a fully humidified atmosphere of 5% CO2 in air, in RPM1 1640 culture medium supplemented with 10% heat-inactivated fetal calf serum (FCS), 1% L-glutamine, and a 1% antibiotic mixture of penicillin, streptomycin, and neomycin (PSN), all from GIBCO-BRL (Gaithersburg, MD). They were subcultured twice a week and studied in the exponential growth phase.
Glycosaminoglycans. Other reagents. Phosphate buffer without calcium or magnesium (PBS), bovine serum albumin (BSA). 12-0-tetradecanoylphorbol-13-acetate (TPA), staurosporine, and cycloheximide were purchased from Sigma (St Louis, MO).
Antigen expression analysis by c)fo/luorometr!~. Cells (2 X IO5) were incubated with 2 pg MoAb (saturating concentration) and then with 2 pg GAM-FITC; each incubation was performed at 4°C for 30 minutes in 40 pL PBS/2% BSA, and was followed by three washes with PBS/2% BSA. As a negative control, the MoAb was replaced by murine IgG of the same isotype (Immunotech). Cell fluorescence intensity was measured using a Profile I1 Coulter counter (Coulter Immunology, Hialeah, FL).
Cell adhesion t o immobilized hvuluronan. Glycosaminoglycans were covalently linked to Costar culture wells (Costar Corp, Cambridge, MA) (diameter: 2.5 cm) according to Turley and Roth." Briefly, polysulfonamide wells were prepared by successive treatment with concentrated sulfuric acid and aqueous ammonium hydroxide (30% vol/vol). After thorough washing with distilled water, the wells were incubated for 48 hours in a humidified atmosphere at 37°C. with 5 mg/mL of either hyaluronan or chondroitin sulfate dissolved in aqueous solution containing 25 mg/mL of 1-ethyl-3-(3-dimethylaminopropyl)carhodiimide. Wells were again thoroughly washed with PBS and used for the cell-adhesion assay, for which IO' cells were incubated for 1 hour at 37°C with 100 pC Nemours, France) in 1 mL FCS, according to Miyake et al." "Crlabeled cells were washed three times with PBS/2% BSA, resuspended in RPM1 1640 medium/2% BSA, and inoculated into glycosaminoglycan-coated wells at the concentration of 2 X IO5 cells/ 300 pL of medium per well. To determine nonspecific adhesion, cells also were inoculated into uncoated wells and into wells coated with 2% BSA. After incubation for 90 minutes at 37°C in a fully humidified atmosphere with 5% CO2 in air, the unbound cells were removed by four cycles of washing in prewarmed PBS/2% BSA, and bound cells were lysed with 0.5%) Triton X-100 for 30 minutes at 37°C. The "Cr radioactivity was counted with a gamma counter (1270 Rack-gammall, LKG-Wallach, Oy, Finland). The percentages of bound cells were calculated according to Miyake et al," using the formula:
Spontaneously released cpm were determined by centrifuging a cell inoculum incubated in RPMI 1640/2% BSA during the experiment and measuring the cpm in the supernate.
Cell aggregation in solutions containing hyaluronan. The binding of hyaluronan in solution has been reported to induce cell aggregation.' Accordingly, IO' cells, previously washed twice with PBS, were suspended in 500 pL RPMI 1640 medium/2% BSA containing 50 pg of either hyaluronan or chondroitin sulfate. After 15 to 120 minutes of incubation at room temperature on a rotating shaker. the formation of aggregates was microscopically examined on a IO-pL sample, using a Malassez hemocytometer. The percentage of aggregating cells was calculated according to Rothlein and Springer?' using the formula:
Each measure was made in triplicate. The number of cells per aggregate was also examined.
Antibodv-blocking experiments. KG1 and KGla cells (3 X IO5) were incubated for 20 minutes at 4°C in 500 pL PBS/2% BSA containing 5 pg of an anti-CD44 MoAb. Control cells without antibody were incubated with 5 pg of murine IgG of the same isotype. Cells were then processed for adhesion or aggregation studies as described above.
Effect ofstaurosporine, TPA, and cycloheximide. on hyahronan binding and CD44 e.xpression. Cells (3 X IO5) were suspended in I mL RPMI 1640 medium/lO% FCSi. They were incubated either with IO" moI/L TPA, for 15 or 30 minutes, I , 3. or 20 hours or with I O to 40 nmol/L staurosporine for 20 hours. In some experiments, as specified in Results, cells were treated overnight with IO pg/mL cycloheximide. At the end ofthese incubations, treated cells and untreated control cells were enumerated and their viability was determined by a trypan blue exclusion test; their hyaluronan-binding ability was determined using the adhesion or aggregation assays described above.
The expression of CD44 was measured using immunofluorescent labeling and cytofluorometry.
Statistical analysis. Means were compared using the adjusted Student t-test.*' Values were considered significantly different when P < .05.
RESULTS

CD44 Was Strongly Expressed in the KGI, KGla, and HL60 Cell Lines
Mean fluorescence intensity was similar on KG1 and KGla cells, for which it was significantly higher (about six times) than on HL60 cells (Fig 1) . Similar fluorescence intensities were obtained with each of the four anti-CD44 MoAbs used. on fresh hyaluronancoated wells; they did not adhere. The expression of CD44 on nonadherent KG1 cells was lower than on the adherent cells (peak position: 240 v 439), but no difference was detected for KGla cells. HL60 cells did not bind spontaneously to hyaluronan. None of these cell lines adhered to chondroitin sulfate, a sulfated glycosaminoglycan that is closely related to hyaluronan and has been reported to be a possible ligand of CD44.
KG1 and KGla
As shown in Fig 2, adhesion of both KG 1 and KG 1 a cells to hyaluronan was strongly inhibited (80% to 90%) by the anti-CD44 MoAbs 5173, T61/7, and T153/G8. This indicated that CD44 mediated the adhesion of KG 1 and KG I a cells to hyaluronan. The H90 MoAb to CD44 also inhibited the adhesion of KG1 cells effectively, by 61% f 5%, but it only inhibited the adhesion of KG la cells by 23% * 4%. The percentage of inhibition by H90 of cell adhesion could not be increased even when it was used at concentrations up to 20 &mL. This suggested that H90 did not recognize the same epitope as J 173, T6 1/7, and T 153/G8 antibodies. This was confirmed by an experiment which showed that the mean fluorescence intensity doubled when cells were simultaneously labeled with H90 and either 5173, T61/7, or T153/G8.This experiment also showed that 5173, T61/7, and T153/G8 MoAbs mapped to close or identical epitopes.
Taken together, these results indicated that the epitopes mapped by J 173, T6 1 /7, and T 153/G8 MOAS were involved in hyaluronan-adhesion of both KG1 and KGla cells, whereas the epitope mapped by the H90 MoAb was highly involved in hyaluronan-adhesion of KG 1 but not of KG 1 a cells. 
KG1 and KGla Cells, But Not HL60 Cells, Aggregated in Hyaluronan Solutions; Anti-CD44 Antibodies Inhibited This Aggregation
KGla and KG1 cells spontaneously formed aggregates when they were incubated in solutions containing hyaluronan, whereas HL60 cells did not. The aggregation of KGla and KG1 cells was maximal at 30 minutes, and thereafter remained stable for about 8 hours at 28.2% k 6.4% and 44.3% +. 4.9%, respectively ( P < .05). The aggregates, comprising 10 to 20 cells, were specific for hyaluronan, because they were abolished by Streptomyces hyaluronidase treatment before incubation and did not form in medium without hyaluronan or in medium containing chondroitin sulfate; only a few clumps of less than four cells were observed in the latter medium. Aggregation of KGla and KG1 cells in the presence of hyaluronan was prevented when the cells were preincubated with anti-CD44 antibodies, H90 antibody reduced KG1 cell aggregation more than KGla cell aggregation by 65% versus 15%.
Staurosporine Inhibited Hyaluronan Binding by KG1 and KGla Cells. TPA Enhanced It by Provoking Protein Neosynthesis
Staurosporine. To determine whether hyaluronan binding by KG 1 and KG I a cells involves protein kinases, cells were pretreated with staurosporine, a potent inhibitor of protein kinase C.28-30 It has been recently shown that staurosporine also inhibited, to a lower extent, protein kinase A.28329 Staurosporine used at low doses, such as 10 to 40 nmol/L, was reported to have a full inhibitory effect, which was usually detectable under physiological conditions, after (Fig 3) . A slight decrease in the intensity of CD44 expression by KG1 cells was observed after treatment with 40 nmol/L staurosporine (Fig 4B) . TPA. TPA is a phorbol ester that stimulates protein kinase C a~tivity.~' We attempted to establish whether, as reported for several lymphoid cell lines, TPA induces or increases CD44-mediated hyaluronan binding by KG I, KG 1 a, and HL60 cell lines. Twenty hours of TPA treatment raised to 80% the proportion of both KG1 and KGla cells that adhered to immobilized hyaluronan (Fig 3) and formed aggregates in solutions containing hyaluronan (data not shown). It increased the expression of CD44 on KG1 cells but not on KG la cells (Figs 4A, C) . In contrast, TPA did not induce hyaluronan binding by HL60 cells; a slight increase of CD44 level on their surface was observed. The aggregates formed by TPA-treated KG la and KG l cells comprised up to 50 cells; that is, more than the untreated cell aggregates, but in the absence of hyaluronan, TPA-treated cells only formed a few small aggregates of less than eight cells. This hyaluronan dependence of TPA-induced adhesion and aggregation was confirmed by showing that these processes were inhibited when hyaluronan was degraded with Streptomyces hyaluronidase. The TPA-induced enhancement of adhesion to hyaluronan was not detectable earlier than about 20 hours of treatment, and it was abolished by cyclophosphamide, an inhibitor of protein synthesis. Unlike spontaneous adhesion, TPA-enhanced adhesion of both KG 1 and KG I a cells to hyaluronan was only partially inhibited, by 56% -t 5% and 27% ? 4%, respectively, by the T61/7 MoAb to CD44. Similar results were obtained using the aggregation assay.
DISCUSSION
Little is known about the function of CD44 on myeloid cells. In the present work, the hyaluronan-binding ability of the myeloid cells KG I , KG la, and HL60 has been analyzed by measuring their capacity to adhere to immobilized hyaluronan and to form aggregates in solutions containing hyaluronan. These assays show that 45% of KG1 cells and 22% to 24% of KG I a cells spontaneously bind hyaluronan; this binding is specifically inhibited by MoAbs to CD44. The phorbol ester TPA rises to 80% the proportion of KG 1 and KGla cells that bind hyaluronan. On the contrary, HL60 cells do not bind hyaluronan either spontaneously or after treatment with TPA.
Hyaluronan-binding ability might depend on a strong expression of CD44, because KG I and KGla cells, which bound hyaluronan, expressed CD44 significantly more than HL60 cells, which did not bind it (Table 1) . Besides, the fraction of KG1 cells that effectively bound to hyaluronan, stained more brightly for CD44 than the fraction that did not bind it. In agreement with this hypothesis, it was shown that several molecules of CD44 can bind to the same molecule of hyaluronan, and that such multiple interactions increase binding affinity beyond that of a monovalent react i~n .~' However, hyaluronan-binding ability does not depend exclusively on the intensity of CD44 expression, because in spite of expressing similar amounts of CD44 as KG1 cells, KG la cells bound to hyaluronan half as much as KG 1 a cells (Table 1, Fig l) . Furthermore, TPA, which strikingly enhanced hyaluronan-binding by the two cell lines, did not increase expression of CD44 on KG l cells (Fig 4C) . Differences in the conformation ofthe CD44 molecules might account for the difference in hyaluronan-binding ability of KG 1 and KG 1 a cells. Two main observations argue in favor of this hypothesis. First, the conformation of the hyaluronan-binding sites seems to differ, because the epitope mapped by the H90 MoAb was involved in hyaluronanbinding of KG1 but not of KGla cells (Fig 2) . This conformational difference could result in a different affinity of the hyaluronan-binding site for its ligand. Second, the CD44-R1 isoform has been reported not to bind hyaluronan, and it has been suggested that the presence of an additional peptide sequence in the extracytoplasmic domain of the molecule may result in conformational changes of the binding domain.33 The higher amount of the CD44-RI isoform in KG I a than in KG 1 cells34 may contribute to the lower hyaluronan-binding ability of KGla cells. The intracytoplasmic domain of CD44, which is important for hyaluronan binding,15 may also differ in the two cell lines.
Hyaluronan-binding by KGla and KG1 cells requires phosphorylation, for it is abolished by staurosporine, a protein kinase inhibitor and strongly enhanced by the phorbol ester TPA, which activates protein kinase C (PKC). Both PKC and PKA may participate in this phosphorylation because staurosporine has been reported to inhibit the activity ofthe two enzyme^.'^-'^ At present, there is no evidence suggesting a role of PKA in the functional regulation of CD44. On the contrary, PKC was reported to have a role in the activation of hyaluronan nonbinding CD44 molecules,35 and a PKC-like molecule is associated to CD44 in lymphoma cells.36
In KG1 and KGla cells, PKC seems to be mainly involved in conformational changes and focal clustering of CD44, because its inhibition by staurosporine (Fig 3) was accompanied by minor changes in the level of CD44 on the cell surface (and only on KG I cells; Fig 4B) . By analogy with integrin~,~' conformation and focal clustering of CD44 are assumed to involve somehow an interaction with the cyt o~k e l e t o n .~~-~~-~*~ However, at present, the role of PKC in the control of this association has not been shown, and conflicting data have been obtained in a wide range of cell types. Thus, PKC was shown to phosphorylate CD44 directly in lymphoma cells and to enhance its binding to ankyrin, a membrane-associated cytoskeletal protein.36 On the contrary, it remains unproved that PKC mediates the CD44-cytoskeleton interaction in macrophages, although this interaction requires phosph~rylation.~~ Furthermore, CD44 phosphorylation could be unnecessary for this interaction, as shown in fibroblasts and epithelial cell^.^^,^ Because it is now known that different isoforms of PKC, with distinct substrates, are specifically expressed in certain cell types:' it could be relevant to characterize the PKC isoforms present in KG1 and KGla cells, and its substrates (CD44 and CD44-associated proteins, such as the cytoskeletal protein a n k~r i n~~) .
Hyaluronan-binding by KGla and KG1 cells is strongly enhanced by the phorbol ester TPA (Fig 3) . TPA may activate the hyaluronan-binding function of inactive molecules of CD44 via PKC, as it was reported in the case of lymphoid cells.35 The effect of TPA is dependent on protein synthesis, because it was fully inhibited by the protein synthesis inhibitor, cycloheximide. In the case of KG1 cells, the newly synthesized proteins may comprise CD44, because cytofluorometric studies showed that it was more brightly expressed on these cells (Fig 4) . However, the enhancing effect of TPA seems to be also related to the production of hyaluronanbinding proteins distinct from CD44, because it was only partly prevented by the anti-CD44 antibody T6 1/7, which is an antibody fully active in inhibiting the spontaneous binding. One of these proteins might be hyaluronectin, which binds specifically hyaluronan and is produced by circulating monocyte^.^^ This hypothesis is currently being investigated in our laboratory.
In conclusion, we have shown that KGla and KG1 cells spontaneously bound hyaluronan by the means of CD44. Thus, KG l a and KG 1 cells strikingly differ from the other myeloid cell lines studied till now: HL60, M1.16, Wehi 3, 745.6, and DIB. 10 (ref 9 and this report). They also differ from the whole population of BM cells, which is a mixture of cells from the three myeloid lineages at various steps of m a t~r a t i o n .~.~~ Unlike all those cells, KG1 and KGla are pure populations of very primitive myeloid cells that express, like hematopoietic stem cells and myeloid progenitors, the CD34 antigen. Therefore, our results suggest that the hyaluronan-binding ability of myeloid cells might vary during differentiation, and it might be a characteristic of the primitive CD34' myeloid cells. This hypothesis is currently being checked in our laboratory. If it is valid, it would imply that CD44-mediated binding of hyaluronan plays a role in the interaction of primitive myeloid cells with the hematopoietic stroma.
